Jan C. Schmollinger

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Immunotherapy is currently investigated as treatment option in many types of cancer. So far, results from clinical trials have demonstrated that significant benefit from immunomodulatory therapies is restricted to patients with select histologies. To broaden the potential use of these therapies, a deeper understanding for mechanisms of immunosuppression in(More)
  • 1